Claris Ventures
Claris Ventures is a venture capital firm based in Turin, Italy, that pursues early-stage investments in biopharma companies emerging from Italy's research and development ecosystem.
Top Stages
Past deals in Italy
Kither Biotech
Series B in 2022
Kither Biotech, established in 2011 and based in Turin, Italy, specializes in researching and developing drugs targeting pulmonary diseases with unmet medical needs. Its primary focus is on two internally developed compounds: KIT2014, a peptide currently in pre-clinical development for treating cystic fibrosis, which has received orphan drug designation from the EMA; and CL27, a molecule intended for chronic obstructive pulmonary diseases and allergic asthma, also in its pre-clinical phase.
Kither Biotech
Series A in 2019
Kither Biotech, established in 2011 and based in Turin, Italy, specializes in researching and developing drugs targeting pulmonary diseases with unmet medical needs. Its primary focus is on two internally developed compounds: KIT2014, a peptide currently in pre-clinical development for treating cystic fibrosis, which has received orphan drug designation from the EMA; and CL27, a molecule intended for chronic obstructive pulmonary diseases and allergic asthma, also in its pre-clinical phase.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.